Aceto Execs Hit With Derivative Suit Over Stock Drop
A shareholder of pharmaceutical manufacturer Aceto Corp. filed a derivative suit in New York federal court Wednesday accusing company executives of misleading investors by failing to disclose an impending financial loss...To view the full article, register now.
Already a subscriber? Click here to view full article